VF
ALNA

Virtu Financial’s Allena Pharmaceuticals ALNA Stock Holding History

Virtu Financial’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-43,414
Closed -$10K – 2357
2022
Q1 		$10K Sell
43,414
-90,415
-68% -$37.4K ﹤0.01% 1365
2021
Q4 		$79K Buy
+133,829
New +$105K 0.01% 1223

Other funds holding ALNA

TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Virtu Financial's ALNA Position: Q2 2022 in Review

Virtu Financial sold out of Allena Pharmaceuticals (ALNA) in Q2 2022, closing a stake of 43,414 shares — an estimated $10K sold.

Virtu Financial first reported a position in ALNA in Q4 2021 and held it in 2 quarters. The position peaked at $79K in Q4 2021. 25 funds tracked by Wall St. Rank hold ALNA as of Q2 2022.

  • Virtu Financial reported no remaining Allena Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Virtu Financial sold 43,414 Allena Pharmaceuticals shares in Q2 2022, an estimated $10K.
  • Virtu Financial first reported a position in Allena Pharmaceuticals in Q4 2021 and held it in 2 quarters.
  • Virtu Financial's Allena Pharmaceuticals position peaked at $79K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2022.

Based on Virtu Financial's 13F filing for Q2 2022, filed 9 Aug 2022.